Mirae Asset Global Investments
NMRA icon

Mirae Asset Global Investments’s Neumora Therapeutics NMRA Stock Holding History

Mirae Asset Global Investments’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.1K Sell
8,287
-428
-5% -$815 ﹤0.01% 1529
2026
Q1 		$17K Buy
8,715
+596
+7% +$1.54K ﹤0.01% 1450
2025
Q4 		$14.5K Buy
8,119
+1,858
+30% +$4.07K ﹤0.01% 1579
2025
Q3 		$11.4K Buy
6,261
+13
+0.2% +$21 ﹤0.01% 1562
2025
Q2 		$4.58K Buy
6,248
+842
+16% +$638 ﹤0.01% 1544
2025
Q1 		$5.57K Buy
5,406
+22
+0.4% +$38 ﹤0.01% 1508
2024
Q4 		$61K Buy
+5,384
New +$64.5K ﹤0.01% 1239

Other funds holding NMRA

WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
LC
Lunate Capital Al Maryah Island, Abu Dhabi, United Arab Emirates $196M AUM 84.21% 1-Year Est. Return
AH
Addis & Hill Wayne, Pennsylvania $181M AUM 21.74% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
LPT
Legacy Private Trust Neenah, Wisconsin $1.81B AUM 19.87% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
PWA
Physician Wealth Advisors Midvale, Utah $837M AUM 26% 1-Year Est. Return

Mirae Asset Global Investments's NMRA Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Neumora Therapeutics (NMRA) stake by 4.9% in Q2 2026, selling an estimated $815 and leaving 8,287 shares worth $14.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1529.

Mirae Asset Global Investments first reported a position in NMRA in Q4 2024 and has held it in 7 quarters since. The position peaked at $61K in Q4 2024. 14 funds tracked by Wall St. Rank hold NMRA as of Q2 2026.

  • Mirae Asset Global Investments held 8,287 shares of Neumora Therapeutics worth $14.1K as of Q2 2026.
  • Mirae Asset Global Investments sold 428 Neumora Therapeutics shares in Q2 2026, an estimated $815.
  • Neumora Therapeutics made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1529 holding.
  • Mirae Asset Global Investments first reported a position in Neumora Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • Mirae Asset Global Investments's Neumora Therapeutics position peaked at $61K in Q4 2024.
  • 14 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.